SG
CANF

StoneX Group’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

StoneX Group’s Portfolio CANF Stock Details CANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-200
Closed -$91K – 477
2021
Q2 		$91K Buy
+200
New +$87.7K 0.01% 464

Other funds holding CANF

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

StoneX Group's CANF Position: Q3 2021 in Review

StoneX Group sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q3 2021, closing a stake of 200 shares — an estimated $91K sold.

StoneX Group first reported a position in CANF in Q2 2021 and held it in 1 quarter. The position peaked at $91K in Q2 2021. 12 funds tracked by Wall St. Rank hold CANF as of Q3 2021.

  • StoneX Group reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • StoneX Group sold 200 Can-Fite BioPharma American Depositary Shares shares in Q3 2021, an estimated $91K.
  • StoneX Group first reported a position in Can-Fite BioPharma American Depositary Shares in Q2 2021 and held it in 1 quarter.
  • StoneX Group's Can-Fite BioPharma American Depositary Shares position peaked at $91K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q3 2021.

Based on StoneX Group's 13F filing for Q3 2021, filed 20 Oct 2021.